# Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

> **NCT02742675** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 200 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Bicalutamide
- **DRUG:** goserelin acetate
- **DRUG:** flutamide
- **DRUG:** leuprolide acetate
- **DRUG:** triptorelin
- **PROCEDURE:** Definitive Treatment

## Key facts

- **NCT ID:** NCT02742675
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2021-03
- **Final completion:** 2023-03
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02742675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02742675, "Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02742675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*